Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kraus, Benjamin ^a   Fischer, Katrin ^a   Büchner, Sarah M ^a   Wels, Winfried S ^b   Löwer, Roswitha ^a   Sliva, Katja ^a   Schnierle, Barbara S ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL KILLING; ENDOGENOUS RETROVIRUS; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS K; KIDNEY CARCINOMA; LUNG METASTASIS; MOUSE; MURINE MODEL; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; VACCINATION; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CHICKENS; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENDOGENOUS RETROVIRUSES; FEMALE; GLYCOPROTEINS; HEK293 CELLS; HUMANS; IMMUNITY, CELLULAR; LUNG NEOPLASMS; MICE; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 84883354311     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072756     Document Type: Article

References (47)

1. Subramanian RP, Wildschutte JH, Russo C, Coffin JM, (2011) Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8: 90.
2. Bannert N, Kurth R, (2006) The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet 7: 149-173.
3. Rowe HM, Trono D, (2011) Dynamic control of endogenous retroviruses during development. Virology 411: 273-287.
4. Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, et al. (2011) Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PLoS ONE 6: e20234.
5. Lower R, Lower J, Frank H, Harzmann R, Kurth R, (1984) Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol 65 (Pt 5): 887-898.
6. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, et al. (2005) Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 65: 4172-4180.
7. Hahn S, Ugurel S, Hanschmann KM, Strobel H, Tondera C, et al. (2008) Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retroviruses 24: 717-723.
8. Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, et al. (2007) Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 120: 81-90.
9. Herbst H, Kuhler-Obbarius C, Lauke H, Sauter M, Mueller-Lantzsch N, et al. (1999) Human endogenous retrovirus (HERV)-K transcripts in gonadoblastomas and gonadoblastoma-derived germ cell tumours. Virchows Arch 434: 11-15.
10. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, et al. (2003) Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22: 1528-1535.
11. Ejthadi HD, Martin JH, Junying J, Roden DA, Lahiri M, et al. (2005) A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer. Arch Virol 150: 177-184.
12. Depil S, Roche C, Dussart P, Prin L, (2002) Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia 16: 254-259.
13. Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, et al. (2008) Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun 8: 15.
14. Goering W, Ribarska T, Schulz WA, (2011) Selective changes of retroelement expression in human prostate cancer. Carcinogenesis 32: 1484-1492.
15. Contreras-Galindo R, Lopez P, Velez R, Yamamura Y, (2007) HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses 23: 116-122.
16. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y, (2006) Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Hum Retroviruses 22: 979-984.
17. Contreras-Galindo R, Gonzalez M, modovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, et al. (2006) A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J Virol Methods 136: 51-57.
18. Contreras-Galindo R, modovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, Yamamura Y, (2007) Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. AIDS Res Hum Retroviruses 23: 1083-1086.
19. Laderoute MP, Giulivi A, Larocque L, Bellfoy D, Hou Y, et al. (2007) The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia. Aids 21: 2417-2424.
20. Jones RB, John VM, Hunter DV, Martin E, Mujib S, et al. (2012) Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening. Clin Vaccine Immunol 19: 288-292.
21. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, et al. (2007) T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection. PLoS Pathog 3: e165.
22. SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, et al. (2011) Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection. J Virol 85: 6977-6985.
23. Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, et al. (2012) HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. J Clin Invest 122: 4473-4489.
24. Sacha JB, Kim IJ, Chen L, Ullah JH, Goodwin DA, et al. (2012) Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic. J Immunol 189: 1467-1479.
25. Kammerer U, Germeyer A, Stengel S, Kapp M, Denner J, (2011) Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta. J Reprod Immunol 91: 1-8.
26. Jager E, Karbach J, Gnjatic S, Neumann A, Bender A, et al. (2006) Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. Proc Natl Acad Sci U S A 103: 14453-14458.
27. Gomez CE, Najera JL, Krupa M, Perdiguero B, Esteban M, (2011) MVA and NYVAC as vaccines against emergent infectious diseases and cancer. Curr Gene Ther 11: 189-217.
28. Staib C, Lowel M, Erfle V, Sutter G, (2003) Improved host range selection for recombinant modified vaccinia virus Ankara. Biotechniques 34: 694-6.
29. Staib C, Drexler I, Sutter G, (2004) Construction and isolation of recombinant MVA. Methods Mol Biol 269: 77-100.
30. Hanke K, Kramer P, Seeher S, Beimforde N, Kurth R, et al. (2009) Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain. J Virol 83: 12790-12800.
31. Chakrabarti S, Sisler JR, Moss B, (1997) Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23: 1094-1097.
32. Kraus B, Monk B, Sliva K, Schnierle BS, (2012) Expression of Human Endogenous Retrovirus-K Coincides with that of Micro-RNA-663 and-638 in Germ-cell Tumor Cells. Anticancer Res 32: 4797-4804.
33. Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J, (1995) Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol 69: 141-149.
34. Mangeney M, Heidmann T, (1998) Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci U S A 95: 14920-14925.
35. Mangeney M, de Parseval N, Thomas G, Heidmann T, (2001) The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J Gen Virol 82: 2515-2518.
36. Blaise S, Mangeney M, Heidmann T, (2001) The envelope of Mason-Pfizer monkey virus has immunosuppressive properties. J Gen Virol 82: 1597-1600.
37. Maurer-Gebhard M, Schmidt M, Azemar M, Altenschmidt U, Stocklin E, et al. (1998) Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells. Cancer Res 58: 2661-2666.
38. Bannert N, Kurth R, (2004) Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A 101Suppl 2: 14572-14579.
39. Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, et al. (2004) HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors. Int J Cancer 110: 459-461.
40. Humer J, Waltenberger A, Grassauer A, Kurz M, Valencak J, et al. (2006) Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses. Cancer Res 66: 1658-1663.
41. van der Kuyl AC, (2012) HIV infection and HERV expression: a review. Retrovirology 9: 6.
42. Contreras-Galindo R, Kaplan MH, He S, Contreras-Galindo AC, Gonzalez-Hernandez MJ, et al. (2013) HIV Infection Reveals Wide-Spread Expansion of Novel Centromeric Human Endogenous Retroviruses. Genome Res May 8.
43. Gomez CE, Najera JL, Krupa M, Esteban M, (2008) The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer. Curr Gene Ther 8: 97-120.
44. Ramirez JC, Gherardi MM, Esteban M, (2000) Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J Virol 74: 923-933.
45. de Parseval N, Diop G, Blaise S, Helle F, Vasilescu A, et al. (2005) Comprehensive search for intra- and inter-specific sequence polymorphisms among coding envelope genes of retroviral origin found in the human genome: genes and pseudogenes. BMC Genomics 6: 117.
46. Reus K, Mayer J, Sauter M, Zischler H, Muller-Lantzsch N, et al. (2001) HERV-K(OLD): ancestor sequences of the human endogenous retrovirus family HERV-K(HML-2). J Virol 75: 8917-8926.
47. Sverdlov ED, (2000) Retroviruses and primate evolution. Bioessays 22: 161-171.